TPG

TPG Inc. ( TPG ) Q3 2026 Earnings Call October 29, 2026 11:00 AM EDT Company Participants Gary Stein - Head of Investor Relations Jon Winkelried - CEO & Director Axel Philippe Andre - Chief Financial Officer Jack Weingart - CEO of Global Wealth Solutions Business James Coulter - Executive Chairman & Founding Partner Conference Call Participants Benjamin Budish - Barclays Bank PLC, Research Division Glenn Schorr - Evercore ISI Institutional Equities, Research Division Alexander Blostein - Goldman Sachs Group, Inc., Research Division Brennan Hawken - BMO Capital Markets Equity Research Michael Brown - UBS Investment Bank, Research Division Kenneth Worthington - JPMorgan Chase & Co, Research Division Steven Chubak - Wolfe Research, LLC Devin Ryan - Citizens JMP Securities, LLC, Research Division Brian Bedell - Deutsche Bank AG, Research Division Arnaud Giblat - BNP Paribas, Research Division Bart Dziarski - RBC Capital Markets, Research Division Michael Cyprys - Morgan Stanley, Research Division Presentation Operator Good morning, and welcome to TPG's Third Quarter 2026 Earnings Conference Call. [Operator Instructions] Please be advised that today's call is being recorded.

TPG NASDAQ: TPG reported third-quarter 2026 GAAP net income attributable to the company of $100 million and after-tax distributable earnings of $265 million, or $0.65 per Class A share, as fundraising, deployment and assets under management continued to grow across private equity, credit, real estate and wealth products.

While the top- and bottom-line numbers for TPG Inc. (TPG) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

TPG Inc. (TPG) came out with quarterly earnings of $0.65 per share, beating the Zacks Consensus Estimate of $0.63 per share. This compares to earnings of $0.53 per share a year ago.

SAN FRANCISCO & FORT WORTH, Texas--(BUSINESS WIRE)--TPG Inc. (NASDAQ: TPG), a leading global alternative asset management firm, today reported its unaudited results for the third quarter ended September 30, 2026. A detailed presentation is available through the Investor Relations section of TPG's website at shareholders.tpg.com. “TPG delivered an exceptional third quarter, reflecting broad-based momentum across the firm and continued progress across each of our strategic objectives,” said Jon W.

TPG Inc. (TPG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The October 2026 'Dogs of the Russell 3000' strategy highlights high-yield, fair-priced stocks with analyst-projected net gains up to 81.2% by October 2027. Top ten S-M Russell 3000 stocks offer yields from 10.1% to 19.6%, with all currently trading below projected annual dividends from $1,000 invested. Fifteen out of fifty-one S-M Russell 3000 high-yielders have negative free cash flow margins, signaling caution for dividend sustainability.

TPG Inc. is rated Buy with a $55 price target, despite a sharp decline from its 52-week high. TPG's fee-related earnings surged 43% and fee-earning AUM rose 24%, while weak realizations drove the stock lower. Approximately $51.7 billion of AUM is not yet generating full fees, offering significant future revenue potential.

Private equity firm TPG is exploring the sale of Lyric, in a ‌process that could value the software company which supports payments in the healthcare industry at about $5 billion, people close to the discussions said.

UnitedHealth (UNH) stock is inching lower after the healthcare giant confirmed the sale of a partial stake in its Optum Health Florida primary-care clinic network, including WellMed operations, to private equity firm TPG. The transaction allows UNH to bring in strategic growth capital while maintaining an equity interest in the regional clinic footprint.